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Abstract
Diabetic cardiomyopathy (DCM) is a diabetic complication, which results in myocardial dysfunction independent of other
etiological factors. Abnormal intracellular calcium ([Ca
2+]i) homeostasis has been implicated in DCM and may precede
clinical manifestation. Studies in cardiomyocytes have shown that diabetes results in impaired [Ca
2+]i homeostasis due to
altered sarcoplasmic reticulum Ca
2+ ATPase (SERCA) and sodium-calcium exchanger (NCX) activity. Importantly, altered
calcium homeostasis may also be involved in diabetes-associated endothelial dysfunction, including impaired endothelium-
dependent relaxation and a diminished capacity to generate nitric oxide (NO), elevated cell adhesion molecules, and
decreased angiogenic growth factors. However, the effect of diabetes on Ca
2+ regulatory mechanisms in cardiac endothelial
cells (CECs) remains unknown. The objective of this study was to determine the effect of diabetes on [Ca
2+]i homeostasis in
CECs in the rat model (streptozotocin-induced) of DCM. DCM-associated cardiac fibrosis was confirmed using picrosirius red
staining of the myocardium. CECs isolated from the myocardium of diabetic and wild-type rats were loaded with Fura-2, and
UTP-evoked [Ca
2+]i transients were compared under various combinations of SERCA, sarcoplasmic reticulum Ca
2+ ATPase
(PMCA) and NCX inhibitors. Diabetes resulted in significant alterations in SERCA and NCX activities in CECs during [Ca
2+]i
sequestration and efflux, respectively, while no difference in PMCA activity between diabetic and wild-type cells was
observed. These results improve our understanding of how diabetes affects calcium regulation in CECs, and may contribute
to the development of new therapies for DCM treatment.
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Introduction
Diabetes mellitus is a growing epidemic in the United States
that afflicts 8.3% of the total US population [1]. Diabetic
cardiomyopathy (DCM) is a diabetes-associated condition, which
is defined as changes in the structure and function of the
myocardium, independent of other etiological factors [2]. Despite
the potential importance of DCM, the complex and multifactorial
nature of the cellular and molecular perturbations, which may
alter myocardial function, remain poorly understood.
Studies in animal models have shown that diabetes results in
abnormal calcium (Ca
2+) homeostasis that may precede clinically
manifested DCM-related cardiac dysfunction [3,4]. Importantly,
alterations in Ca
2+ regulatory mechanisms are a hallmark of
cardiomyopathy and heart failure in human patients [4]. During
normal myocardial contraction, intracellular Ca
2+ concentration
([Ca
2+]i) in cardiomyocytes increases due to Ca
2+ entry via Ca
2+
channels and inositol trisphosphate (IP3) mediated Ca
2+ release
from sarco/endoplasmic reticulum (SER). Cardiac relaxation is
subsequently initiated by the Ca
2+ decay process, which is
governed by Ca
2+ sequestration and Ca
2+ efflux mechanisms.
During Ca
2+ sequestration, the sarcoplasmic reticulum Ca
2+
ATPase pumps (SERCA) re-sequester the Ca
2+ from the cytosol
back to the SER. Similarly the Ca
2+ efflux mechanism extrudes
Ca
2+ via plasma membrane Ca
2+ ATPase pumps (PMCA), and
sodium- calcium exchangers (NCX) [5–7].
In recent reports, diabetic cardiomyocytes displayed reduced
SERCA activity and Ca
2+ sequestration, as well as impaired NCX
function [8,9]. Similarly, aortic and arterial smooth muscle cells
isolated from diabetic rats have shown reduced Ca
2+ signaling [10]
and abnormalities in SER Ca
2+ mobilization [8]. Furthermore,
SERCA overexpression in transgenic mice resulted in the
protection against cardiac dysfunction in streptozotocin-induced
diabetes [11]. Overall, these results suggest potential mechanisms
for diabetes-induced disruptions in Ca
2+ homeostasis.
It is well established that endothelium plays an essential role in
vascular function, including nitric oxide (NO) -mediated modu-
lation of vascular tone, control of adhesion between the vessel and
cells circulating in the blood, and regulation of local cell and vessel
growth via a variety of growth factors. Calcium is an important
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pathways, including signaling via NO [12,13], cell adhesion
molecules [14,15], and receptor tyrosine kinases [16,17]. Impor-
tantly, diabetes is associated with impaired endothelium-depen-
dent relaxation and diminished capacity to generate NO [18–21],
elevated cell adhesion molecules [22,23], and decreased angio-
genic growth factors [24,25]. Despite the available evidence of a
link between calcium signaling and endothelial cell function, as
well as documented endothelial dysfunction in diabetes, the
possible effects of diabetes on Ca
2+ signaling in endothelial cells
are not known, which may delay the development of vascular
therapies for diabetic patients. In particular, the information
regarding the effects of diabetes on Ca
2+ regulation in cardiac
endothelium is especially important, because cardiac endothelial
cells (CECs) are instrumental in normal myocardial function,
including endocardium interactions, myocardial capillaries, vas-
cular permeability and cardiac tissue remodeling. Therefore, this
information is essential for a better understanding of mechanisms
for the impaired cardiac function in DCM and for the
development of new therapies to treat this condition.
The objective of this study was to determine the effect of
diabetes on intracellular Ca
2+ homeostasis in CECs in a rat model
(streptozotocin-induced) of DCM. Uridine-59-triphosphate (UTP)
-evoked [Ca
2+]i transients were compared between diabetic and
wild-type CECs under various combinations of SERCA, PMCA
and NCX inhibitors. Our results demonstrate that diabetes results
in altered Ca
2+ homeostasis in endothelial cells via decreases in
SERCA and NCX activities during Ca
2+ sequestration and Ca
2+
efflux, respectively.
Results
Effect of SERCA, NCX and PMCA inhibitors on [Ca
2+]i
transients in wild-type CECs
The objective of these experiments was to establish the baseline
for normal (wild-type) CEC response to SERCA, NCX and
PMCA inhibitors. Consistent with previous studies [26], UTP (a
P2Y2 receptor agonist) evoked a [Ca
2+]i transient which decayed to
basal level (Fig. 1A). The decay time of UTP-evoked [Ca
2+]i
transient was significantly higher in the presence of SERCA
inhibitor, thapsigargin (Fig. 1B, p,0.05). The effect of thapsi-
gargin was further confirmed by the subsequent addition of
2.0 mmol/L Ca
2+ to the medium, which evoked a marked [Ca
2+]i
increase due to the depletion of SER and Ca
2+ influx through
store-operated Ca
2+ channels (data not shown).
As expected, in the presence of NCX inhibitor (benzamil), the
Ca
2+ decay time (Fig. 1C) was significantly increased in CECs as
compared to no inhibitor controls (Fig. 1E, p,0.05). Similarly, the
presence of carboxyeosin (carbEO), a selective PMCA inhibitor
resulted in a significant increase in the decay time of UTP-evoked
[Ca
2+]i transient, as compared to no inhibitor treated CECs
(Fig. 1D, E, p,0.05). These experiments were performed in Ca
2+
free solution to avoid any contributions of Ca
2+ influx from the
extracellular space. To further validate these results, experiments
were repeated in the presence of extracellular Ca
2+, which also
resulted in slower [Ca
2+]i decay time in wild-type CECs (data not
shown) consistent with previous reports [27].
The [Ca
2+]i peak amplitude in wild-type CECs remained
similar in the presence of SERCA and PMCA inhibitors as
compared to no inhibitor controls. However, cells treated with
NCX inhibitor showed a higher [Ca
2+]i peak as compared to no
inhibitor controls (Fig. 1F, p,0.05).
Figure 1. Effect of SERCA, NCX and PMCA inhibition on [Ca
2+]i
transients in wild-type CECs. [Ca
2+]i transients were evoked by UTP
in the absence (A) or presence of SERCA (thapsigargin), NCX (benzamil)
and PMCA (carboxyeosin (carbEO)) inhibitors in wild-type CECs (B, C,
and D). Successful inhibition of SERCA, NCX and PMCA in wild-type
CECs was demonstrated by an increased [Ca
2+]i decay time (E; from 80%
to 20% of its peak amplitude) in the presence of inhibitors (Ca
2+ free
medium). [Ca
2+]i peak amplitude in the presence of NCX inhibitor was
significantly greater then no inhibitor controls (F), while SERCA and
PMCA inhibitors had no affect on peak amplitude (#:p ,0.05; cell no.:
A: 79, B: 88; C: 85, D: 92).
doi:10.1371/journal.pone.0036840.g001
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STZ injection
Measurement of blood glucose levels after STZ injection
showed significant and rapid hyperglycemia by day 5, which
persisted until the end of the experiments (Fig. 2B). The blood
glucose levels of the wild-type control animals remained in the
physiological range for the duration of the study. Picrosirius red
staining of the rat myocardium under polarized light showed
significantly higher levels of cardiac fibrosis (yellow, orange, or red)
in diabetic animals, as compared to tissue from age- and strain-
matched wild-type control animals (p,0.05) [28], where mostly
reticular, non-fibrillar collagen (green) was present (Fig. 2A).
Interestingly, the values for the fibrillar collagen content in both
groups are ,2-fold higher than those reported in the literature
[28,29]. This may be due to the differences in methodology used
to calculate collagen area fraction, including magnification (2X in
this study vs. 200X in previous reports), the analysis of the sections
of the whole heart vs. left ventricle only, and the normalization
procedure (i.e. using the area obtained by tracing the myocardium
to exclude voids in this study vs. the ratio of stained area to the
unstained area in previous reports [28,29]). Importantly, despite
Figure 2. Diabetes induces cardiac fibrosis and alters [Ca
2+]i transients in CECs. (A): Analysis of the Picrosirius red staining of diabetic
myocardium using polarized light microscopy showed the presence of cardiac fibrosis with significantly increased area of fibrillar collagen fibers
(yellow, orange or red, middle panel), as compared to mostly reticular fibers (green, left panel) in the myocardium of age-matched wild-type animals
(LV, RV: left or right ventricle). (B): Rats injected with STZ showed significant and rapid hyperglycemia by day 5 that persisted throughout the study.
(C–F): Significant differences in UTP-evoked [Ca
2+]i transients were observed between wild-type and diabetic CECs (C, D). [Ca
2+]i transients in
individual cells (outlined in white in the first frame) obtained using ratiometric analysis are shown as grey lines, with the average transient as a black
line. Analysis of transients (E–F) demonstrated significantly longer [Ca
2+]i decay time and smaller peak amplitude in diabetic CECs, as compared to
wild-type CECs (#:p ,0.05; cell no: 206 (wt), 195 (db)).
doi:10.1371/journal.pone.0036840.g002
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(approximately 2.5-fold) in the fibrillar collagen content of the
diabetic hearts as compared to the normal tissue is consistent with
previous findings [28,29].
[Ca
2+]i transients are disrupted in diabetic CECs
In wild-type CECs, UTP evoked a [Ca
2+]i transient, which
gradually decayed with time (Fig. 2C, D). Interestingly, in diabetic
CECs, the [Ca
2+]i transient decay was markedly delayed (Fig. 2C,
D). Ratiometric analysis showed that in diabetic CECs, the decay
time was significantly longer (Fig. 2E, p,0.05), and the [Ca
2+]i
peak amplitude was significantly smaller, as compared to wild-type
CECs (Fig. 2F, p,0.05).
Altered Ca
2+ re-sequestration contributes to changes in
[Ca
2+]i transients in diabetic CECs
[Ca
2+]i transients were first evoked by thapsigargin to explicitly
examine Ca
2+ depletion from SER in a Ca
2+ free medium [30]. In
diabetic cells, the peak amplitude was significantly smaller (db:
0.51960.12 vs. wt: 0.72360.05, cell no: 31 (db), 42(wt), p,0.05),
and decay time was significantly longer (db: 131615 vs. wt:
11669, cell no: 42 (db), 38 (wt), p,0.05), as compared to wild-
type CECs, indicating possible alterations in SERCA mediated
Ca
2+ responses in diabetic CECs.
To further examine SERCA-mediated Ca
2+ sequestration
without the contribution of Ca
2+ efflux mechanism during
[Ca
2+]i decay, CECs were treated with PMCA (carboxyeosin)
and NCX (benzamil) inhibitors. Under these conditions, thapsi-
gargin induced a slow and long-lasting Ca
2+ transient in wild-type
CECs. Diabetic CECs showed a similar response, with [Ca
2+]i
decay time similar to that of wild-type CECs (Fig. 3A), while
[Ca
2+]i peak amplitude in diabetic CECs was significantly smaller
than in wild-type CECs (Fig. 3A, p,0.05). Interestingly, when
[Ca
2+]i transient was evoked using UTP in the presence of PMCA
(carboxyeosin) and NCX (benzamil) inhibitors, the [Ca
2+]i decay
time in diabetic CECs was significantly increased and the peak
amplitude was significantly decreased as compared to wild-type
CECs (Fig. 3B, p,0.05). Results for [Ca
2+]i transients evoked in
the presence of extracellular Ca
2+ (2 mM CaCl2 added) were
similar, with significantly increased [Ca
2+]i decay time and
decreased peak amplitude in diabetic CECs as compared to
wild-type (Fig. 3B, p,0.05).
Ca
2+ efflux mechanism is altered in diabetic CECs
CECs were treated with thapsigargin to block the contribution
of the Ca
2+ sequestration mechanism during [Ca
2+]i decay. The
observed [Ca
2+]i decay time was significantly increased in diabetic
CECs, as compared to wild-type cells (Fig. 4A, p,0.05), indicating
impaired Ca
2+ efflux in diabetic cells. A significant decrease in
[Ca
2+]i peak amplitude was also observed in diabetic CECs
(Fig. 4A, p,0.05). The subsequent experiments were performed to
determine whether diabetes affects Ca
2+ efflux mechanism either
via altered PMCA or NCX activity, or a combination of both.
[Ca
2+]i extrusion by PMCA during Ca
2+ efflux is not
altered in diabetic CECs
To compare PMCA activity in wild-type and diabetic CECs,
cells were treated with SERCA and NCX inhibitors (thapsigargin
and benzamil, respectively) to exclude the contributions of
SERCA-mediated Ca
2+ sequestration and NCX-mediated Ca
2+
efflux. Under these conditions, the UTP-evoked [Ca
2+]i transient
did not show a significant difference in [Ca
2+]i decay time in
diabetic CECs, as compared to wild-type (Fig. 4B, p,0.05),
indicating that PMCA effectively extrudes Ca
2+ in both diabetic
and wild-type CECs. Furthermore, no differences in [Ca
2+]i peak
amplitudes of diabetic and wild-type CECs were observed under
these conditions.
Figure 3. Diabetes alters SERCA-mediated Ca
2+ sequestration. Cells were treated with PMCA (carbEO) and NCX (benzamil) inhibitors to study
SERCA activity during Ca
2+ re-sequestration without the contribution of Ca
2+ efflux mechanism. (A): Slow and long-lasting Ca
2+ transients were
evoked by thapsigargin (in Ca
2+ free medium), with no significant difference in decay time between wild-type and diabetic CECs. However the peak
amplitude in diabetic CEC was significantly smaller then in wild-type group. (B): UTP-evoked [Ca
2+]i transients in diabetic cells had significantly longer
decay time and smaller peak amplitude in the absence or presence of extracellular Ca
2+ (#:p ,0.05; cell no: A: 82 (wt), 76 (db); B: 73 (wt), 78 (db)).
doi:10.1371/journal.pone.0036840.g003
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2+ NCX activity without affecting PMCA-mediated efflux. (A): CECs were treated with SERCA inhibitor
(thapsigargin) to study the effect of diabetes on intracellular Ca
2+ efflux mechanism without contributions from Ca
2+ sequestration mechanism. UTP-
evoked [Ca
2+]i decay time was significantly increased and the peak amplitude was decreased in diabetic CECs, as compared to wild-type controls. (B):
CECs were treated with SERCA (thapsigargin) and NCX (benzamil) inhibitors to study the effect of diabetes on PMCA-mediated Ca
2+ efflux. Under
these conditions, there was no significant difference in UTP-evoked [Ca
2+]i transients between diabetic and wild-type CECs. (C): CECs were treated
with SERCA (thapsigargin) and PMCA (carbEO) inhibitors to study the effect of diabetes on NCX-mediated Ca
2+ efflux. In diabetic CECs, NCX activity
was significantly reduced as indicated by increased decay time of UTP-evoked [Ca
2+]i transients. The peak amplitude was also significantly reduced in
diabetic CECs under these conditions. (D): To confirm effect of diabetes on [Ca
2+]i transients, Ca
2+ decay was inhibited by treating CECs with SERCA
(thapsigargin), PMCA (carbEO) and NCX (benzamil) inhibitors. In wild-type CECs, [Ca
2+]i decay was completely blocked, while diabetic CECs still
showed Ca
2+ removal from the cytosol, with [Ca
2+]i decay time significantly faster than that in wild-type CECs. No change in peak amplitude was
observed under these conditions (#:p ,0.05; cell no. A: 69 (wt), 93 (db); B: 83 (wt), 73(db); C: 74 (wt), 71 (db); D 76 (wt), 72 (db)).
doi:10.1371/journal.pone.0036840.g004
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2+ efflux mechanism in
diabetic CECs
[Ca
2+]i transients were evoked by UTP in the presence of
SERCA and PMCA inhibitors (thapsigargin and carboxyeosin,
respectively) to exclude contributions of SERCA-mediated Ca
2+
sequestration and PMCA-mediated Ca
2+ efflux. Interestingly, the
[Ca
2+]i decay time was significantly increased in diabetic CECs as
compared to wild-type (Fig. 4C, p,0.05), indicating altered NCX
activity during the Ca
2+ efflux. [Ca
2+]i peak amplitude in diabetic
CECs was also significantly reduced as compared to wild-type
CECs. To further confirm these results, [Ca
2+]i decay was
inhibited by treating CECs with SERCA (thapsigargin), PMCA
(carboxyeosin) and NCX (benzamil) inhibitors. Under these
conditions, the [Ca
2+]i decay in wild-type CECs was completely
blocked (Fig. 4D). However, in diabetic CECs, there was still Ca
2+
removal from the cytosol, with [Ca
2+]i decay time significantly
faster than in wild-type CECs (Fig. 4D, p,0.05). Under these
conditions, no significant differences in the peak amplitudes of
diabetic and wild-type CECs were observed. The reasons for the
residual Ca
2+ extrusion (Fig. 4D) are not clear, and further studies
are required to investigate the possible cross talk between SERCA
and PMCA pumps.
Diabetes alters NCX expression levels, but does not effect
SERCA and NCX levels
Immunofluorescent staining for SERCA, NCX and PMCA
protein expression levels indicated that NCX expression levels in
diabetic CECs were significantly reduced as compared to wild-
type CECs (Fig. 5, p,0.05), while no effects of diabetes on the
expression levels of SERCA and PMCA proteins where observed
(Fig. 5).
Discussion
The results of this study demonstrate that diabetes results in
significantly altered [Ca
2+]i transients via disruptions in SERCA-
mediated Ca
2+ sequestration and NCX-mediated Ca
2+ efflux
mechanisms. To the best of our knowledge, this is the first report
of the effect of diabetes on intracellular Ca
2+ regulatory
mechanisms and overall Ca
2+ homeostasis in the cardiac
endothelium. These results are consistent with previous studies
in diabetic cardiomyocytes, where altered Ca
2+ handling was
observed in cells isolated from diabetic mice [31] and rats [32].
Similarly, smooth muscle cells isolated from the aortas of type I
diabetic rats showed significant alterations in SER-Ca
2+ kinetics,
resulting in the development of diabetic vascular complications
[8]. Our results demonstrate that in diabetic CECs, alterations in
[Ca
2+]i transients involve a change in the Ca
2+ sequestration
mechanism. This change in Ca
2+ sequestration is due to the
reduced activity of SERCA to re-sequester Ca
2+ upon UTP
activation. The effect of reduced SERCA activity during Ca
2+
sequestration in diabetic CECs appeared more prominent during
Ca
2+ decay, which may be due to the fact that SERCA has a
higher affinity for Ca
2+ as compared to PMCA [5,7,33]. Our
results suggest that the reduced Ca
2+ sequestration was indepen-
dent of SERCA protein expression, since staining for SERCA
protein remained unchanged in diabetic CECs. Taken together,
these results indicate a common mechanism for diabetes-induced
alterations in Ca
2+ sequestration among several cell types,
Figure 5. Diabetes results in decreased NCX protein expression, with no difference in SERCA and PMCA expression levels. Semi-
quantitative analysis of immunofluorescent staining of CECs showed that diabetes significantly reduces the expression levels of NCX protein as
compared to wild-type (NCX: red; blue: cell nuclei, #:p ,0.05). No significant difference in the expression levels of SERCA and PMCA was observed in
diabetic cells as compared to wild-type (SERCA: green; PMCA: yellow; blue: cell nuclei).
doi:10.1371/journal.pone.0036840.g005
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cells.
Our results show that NCX activity during Ca
2+ efflux is altered
in diabetic CECs, as compared to wild-type controls. The exact
role of the NCX in endothelial cells is still unclear. However, it is
generally accepted that this exchanger normally functions (during
the resting stage or when [Ca
2+]i is high) to extrude Ca
2+ out of the
cell [33]. Because of its bidirectional property, it is also thought to
play a critical role in Ca
2+ influx when the intracellular Na
+
concentration is high enough to drive the NCX. Our findings of a
decrease in NCX activity (with no changes in PMCA activity) in
diabetic CECs suggest that the ability of diabetic CECs to
maintain Ca
2+ homeostasis is compromised, which may contribute
to abnormal cardiac function. This reduced ability of NCX to
extrude Ca
2+ may also be related to the reduced NCX protein
levels as shown by the immunofluorescent staining analysis of
diabetic CECs. Our results of altered NCX activity and reduced
protein expression levels in diabetic CECs are consistent with
previous studies in cardiomyocytes [34,35]. In contrast, Hill et al.
[36] showed that in porcine coronary artery smooth muscle cells,
the diabetic condition does not affect Ca
2+ efflux via NCX, while
resulting in altered Ca
2+ efflux via PMCA. Our results also suggest
that in diabetic CECs, PMCA effectively extrudes Ca
2+ in the
presence of SERCA and NCX inhibitors.
Our results show that while diabetic conditions result in
impaired function of SERCA and NCX, there are no differences
in PMCA function and protein expression between diabetic and
wild-type cells. These results are consistent with those by Hill et al.
[36], where PMCA activity in diabetic smooth muscle cells was
similar to that in wild-type cells in the absence of a functional
SERCA. Our results also corroborate those of van Breemen et al.
[37] in smooth muscle cells, which demonstrated that upon
inhibition of NCX and SERCA, Ca
2+ is primarily extruded by the
PMCA. Overall, our findings suggest that abnormal endothelium-
dependent relaxation and diminished capacity to generate NO in
diabetes [19] may result from altered Ca
2+ transients due to
impaired NCX and SERCA, which can reduce activation of
eNOS and NO production by endothelial cells [38]. Also, altered
Ca
2+ transients in diabetic cells may affect ICAM-1-coupled
cytoskeletal rearrangements and endothelial cell interactions with
inflammatory cells [14], consistent with upregulation of ICAM-1
observed in diabetic patients [22].
In this study, we specifically focused on the effects of DCM on
intracellular calcium regulatory mechanisms (calcium sequestra-
tion and efflux), and therefore, the experiments were performed in
the absence of extracellular calcium (unless otherwise stated).
However, in order to elucidate the mechanisms for DCM-induced
alterations in overall calcium signaling, information regarding the
effects of diabetic conditions on store operated calcium entry is
important as well, and will be the subject of future studies.
While the development of DCM and the associated mechanisms
are complex and multifactorial, impaired Ca
2+ homeostasis has
been identified as a hallmark abnormality for this disorder [3].
Numerous approaches have been suggested to treat DCM by
increasing SERCA and NCX expression [11]. In addition, Ca
2+
dependent signaling pathways (such as PKC activity [39]) have
been identified as possible therapeutic strategies. Information
regarding how diabetes affects Ca
2+ homeostasis in cardiac
endothelium is paramount because Ca
2+ dependent pathways in
CECs are involved in endocardium interactions, vascularization
and nitric oxide-mediated cardiac hypertrophy. Furthermore, it
has been recently shown that endothelial cells may be directly
involved in diabetes–induced cardiac fibrosis via endothelial-to-
mesenchymal transition [40]. Therefore, the results of this study
provide a new insight into the effects of diabetes on Ca
2+
regulation in CECs, which may contribute to the design of
therapeutic approaches to target abnormal Ca
2+ homeostasis in
diabetic cardiomyopathy. Further studies will be required to
determine the exact molecular mechanisms for the observed
effects.
Materials and Methods
Ethics statement
All procedures were performed according to the protocols
approved by the University of Cincinnati Institutional Animal
Care and Use Committee (IACUC Protocol # 09-06-24-01).
Animal model of type I diabetes
In this study, a rat model of type I (streptozotocin-induced)
diabetes and non-atherogenic diabetic cardiomyopathy [41] was
used. Eight-week-old female Sprague Dawley rats (SAS SD Strain
400, Charles River) were injected intraperitoneally with 70 mg/kg
streptozotocin (STZ, Sigma-Aldrich) and allowed to develop type I
diabetes for six weeks [41], with diabetic phenotype confirmed by
serum glucose levels greater than 300 mg/dl. To assess DCM-
associated cardiac fibrosis, fibrillar collagen content was measured
using picrosirius red staining of paraffin sections of myocardium
[42]. The stained sections were observed under polarized light and
photographed with the same exposure time for each section. The
percentage of fibrillar collagen (yellow, red or orange color) or
non-fibrillar collagen (green color) relative to the total area of the
myocardium (traced by hand to exclude void areas) was
determined using computer-assisted analysis (Adobe Photoshop
CS3, Adobe Systems Incorporated, CA).
Cardiac endothelial cell isolation and culture
Cardiac cells were isolated from the myocardium of diabetic
and wild-type rats as described previously [43]. CECs were sorted
from cardiac cell mixture using PECAM-1- and ICAM-2-
conjugated magnetic beads (Invitrogen Corporation, CA). Endo-
thelial phenotype was confirmed using von Willebrand Factor
staining (Sigma-Aldrich, MO), with .95% cells positively stained.
CECs were cultured in medium M199 (HyClone, UT) with 10%
fetal bovine serum (Atlanta Biologicals, GA), 1% antibiotic/
antimycotic (AtlantaBiologicals, GA), 1% heparin (Sigma-Aldrich,
MO) and 10 ng/mL endothelial growth factor supplement
(Sigma-Aldrich, MO). CECs from passages 4–9 were used for all
experiments. Prior to Ca
2+ experiments, CECs were trypsinized
and seeded on multi-well glass coverslips (Sigma-Aldrich, MO) for
24 hours.
Measurements of [Ca
2+]i transients
To exclude the contribution of extracellular Ca
2+ influx during
[Ca
2+]i transient, experiments were performed in a Ca
2+ free
medium (Hanks’ balanced salt solution without Ca
2+ and Mg
2+,
supplemented with 25 mM HEPES (Invitrogen Corporation, CA),
0.5% bovine serum albumin (Atlanta Biologicals, GA), 2.5 mM
probenecid (Sigma-Aldrich, MO), pH 7.45) and 0.5 mM EGTA
(calcium buffer), unless otherwise stated. Wild-type and diabetic
CECs were loaded with 5 mMC a
2+ sensitive indicator Fura-2 AM
(Sigma-Aldrich, MO) for 40 minutes at room temperature. In
some experiments, extracellular Ca
2+ was incorporated by adding
2 mM CaCl2 in the Ca
2+ free medium without EGTA. [Ca
2+]i
transients were evoked in CECs by adding 10 mM UTP
(Invitrogen Corporation, CA). UTP has been shown to act on P-
type purinergic receptors (P2Y2), which leads to a G protein-
mediated activation of phospholipase C, followed by inositol 1,4,5-
Diabetes Alters Calcium Transients
PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e36840trisphosphate (IP3) formation and the release of Ca
2+ from IP3
sensitive Ca
2+ stores (mainly from SER) [26]. The imaging setup
included an Olympus IX81 inverted fluorescent microscope
(Olympus, PA) equipped with cooled charged couple device
camera, automated filter wheel (340 nm and 380 nm excitation
wavelengths) and a Fura-2 filter cube (400 diachronic and 510 nm
wide band emission filter). After UTP administration, images at
340 nm (bound Ca2+) and 380 nm (unbound Ca
2+) excitation
wavelengths were recorded at 510 nm emission after every
250 msec for at least 20 minutes. For each time point, F340/
F380 ratiometric analysis was performed by determining the ratio
of 340 nm and the corresponding 380 nm image (ImagePro
software, Media Cybernetics Inc., MD). Regions of interest
outlining cell boundaries on the ratio image were defined, and
the variations in fluorescent intensity of selected cells were
tabulated [44]. The individual traces (shown in gray, Fig. 2D)
were then used to obtain the average intensity as a function of time
(shown in black in Fig. 2D). For every treatment group, each
experiment was repeated at least 3 times using fresh cells, and at
least n=70 individual cell traces were analyzed to obtain the
average intensity plot as shown in Fig. 2D. Standard deviation was
calculated at every time point, and the representative SD error
bars are shown for every 10
th point.
Inhibitor studies
To assess the activities of SERCA, PMCA and NCX during the
decay of [Ca
2+]i transients, wild-type CECs were treated with
1 mM thapsigargin (Sigma-Aldrich, MO), a selective SERCA
inhibitor [45], 100 mM benzamil (Sigma-Aldrich, MO), an NCX
inhibitor [46] or 25 mM carboxyeosin ester (carbEO, Sigma-
Aldrich, MO), a selective PMCA inhibitor [47] (Fig. 1). Cells were
incubated in an inhibitor-containing medium for 30 minutes prior
to Fura-2 administration. For Ca
2+ sequestration mechanism
studies (SERCA activity), [Ca
2+]i transients were first evoked using
1 mM thapsigargin, followed by 10 mM UTP in a Ca
2+ free
medium. During these experiments, the Ca
2+ efflux was inhibited
using PMCA and NCX inhibitors at all times. To examine the
Ca
2+ efflux mechanism (PMCA and NCX activities), diabetic and
wild-type CECs were treated with NCX inhibitor (benzamil) or
PMCA inhibitor (carboxyeosin). These experiments were per-
formed under the following conditions: a) SERCA activity was
inhibited at all times (thapsigargin present in the medium), b)
NCX activity was inhibited to examine PMCA activity, and c)
PMCA activity was inhibited to examine NCX activity. In these
experiments, UTP was used to evoke [Ca
2+]i transients.
Immunofluorescent staining and semi-quantitative
analysis
To investigate the effect of diabetes on the protein expression
levels of SERCA, NCX and PMCA, diabetic and wild-type CECs
were seeded in 24 well plates (6 wells per cell type) and allowed to
spread. At 24 hours after seeding, cells were fixed in 2%
paraformaldehyde. Immunofluorescent staining was performed
by incubating the cells in rabbit anti-rat antibodies against
SERCA, NCX and PMCA (abcam, MA) proteins, followed by
incubation with Alexa Fluor 568-conjugated anti-rabbit secondary
antibody (Invitrogen Corporation, CA). Cells were also stained
with DAPI to identify cell nuclei (Invitrogen Corporation, CA). A
total of 20 images for each protein were captured at 20X
magnification using an Olympus IX81 microscope. The average
fluorescent intensity of each image was quantified using MATLAB
software (The Math Works, MA), and normalized by the intensity
value of the corresponding negative control image (CECs
incubated with only secondary antibody).
Statistical analyses
The decay time of agonist-evoked Ca
2+ transient was deter-
mined as the time in which [Ca
2+]i decayed from 80% to 20% of
its peak amplitude (presented as t80–20). The results are expressed
as mean 6 SD. One way ANOVA (SPSS, IBM, IL) was used to
determine the effect of diabetes on [Ca
2+]i decay kinetics and
protein expression levels in CECs. A p,0.05 was considered to be
statistically significant. All experiments were repeated at least
3 times; at least 70 diabetic/wild-type CECs were analyzed per
treatment.
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